Reference information only. Always consult a qualified healthcare professional.
MPMediPriceHubMedicine price reference
PRODUCT INFORMATION

Dasamed 50mg Tablet

Dasatinib (50mg)

Dasamed 50mg Tablet
Reference priceKRW ₩101,148.75Original source price: INR 6,243.75. Converted estimates are available by currency selection.
BrandMedicamen Biotech Ltd
ManufacturerMedicamen Biotech Ltd
Prescription requiredYes

Description

Dasamed 50mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome.

Benefits

Dasamed 50mg tablet is indicated for the following conditions 1.Children and adults with chronic myeloid leukemia. 2.Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

How to Use

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Specification

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Side Effects

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Dasamed Nausea Constipation Anemia (low number of red blood cells) Rash Vomiting Fatigue Infection Diarrhea Musculoskeletal (bone, muscle or joint) pain Low blood platelets Muscle pain Joint pain Headache Abdominal pain Fluid retention Pleural effusion Localized edema Pulmonary hypertension (high blood pressure)

This information is for reference only. Consult a qualified healthcare professional before using any medicine.